112 related articles for article (PubMed ID: 9378249)
1. Actions of nimodipine on the serotonergic systems of rat brain.
Gaggi R; Dall' Olio R; Santangelo M; Roncada P
Gen Pharmacol; 1997 Sep; 29(3):415-9. PubMed ID: 9378249
[TBL] [Abstract][Full Text] [Related]
2. Interactions between darodipine or isradipine and the 5-HT1A receptor agonist 8-OHDPAT in rat brain.
Gaggi R; D'Allolio R; Santangelo M; Roncada P
Pharmacol Biochem Behav; 1997 Oct; 58(2):299-303. PubMed ID: 9300583
[TBL] [Abstract][Full Text] [Related]
3. Effects of isradipine and darodipine on serotonergic system of the rat brain.
Gaggi R; Dall'Olio R; Roncada P; Gianni AM
Pharmacol Biochem Behav; 1995; 51(2-3):183-7. PubMed ID: 7545305
[TBL] [Abstract][Full Text] [Related]
4. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Green AR; DeSouza RJ; Davies EM; Cross AJ
Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
[TBL] [Abstract][Full Text] [Related]
5. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
6. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
Gronier B
Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine.
Datla KP; Curzon G
Neuropharmacology; 1993 Sep; 32(9):839-45. PubMed ID: 7694170
[TBL] [Abstract][Full Text] [Related]
8. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
10. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2007 May; 192(1):49-59. PubMed ID: 17265149
[TBL] [Abstract][Full Text] [Related]
11. Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties.
Cardenas CG; Del Mar LP; Scroggs RS
J Neurophysiol; 1995 Nov; 74(5):1870-9. PubMed ID: 8592180
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.
Schenk S; Abraham B; Aronsen D; Colussi-Mas J; Do J
Psychopharmacology (Berl); 2013 May; 227(2):355-61. PubMed ID: 23354536
[TBL] [Abstract][Full Text] [Related]
13. Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats.
Robson L; Gower AJ; Kendall DA; Marsden CA
Psychopharmacology (Berl); 1993; 113(2):274-81. PubMed ID: 7531851
[TBL] [Abstract][Full Text] [Related]
14. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
[TBL] [Abstract][Full Text] [Related]
16. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
17. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
19. Development of a presynaptic 5-HT1A antagonist.
Mattson RJ; Catt JD; Sloan CP; Gao Q; Carter RB; Gentile A; Mahle CD; Matos FF; McGovern R; VanderMaelen CP; Yocca FD
Bioorg Med Chem Lett; 2003 Jan; 13(2):285-8. PubMed ID: 12482441
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
